chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: PPV
Symptoms: Injection site reaction
Clinical narrative: This spontaneous report as received from a physician via field representative refers to a two patients of unknown age and gender, who on an unknown dates were vaccinated with doses of PNEUMOVAX 23 with the same lot number (not specified) (doses and routes were not reported). On an unknown dates in 2013 (reported as "in about three weeks") patients experienced unspecified injection-site reactions. The outcome of the events was not reported. The relatedness between events and PNEUMOVAX 23 was not reported. This is one of several reports received from the same source (related MARRS # 1306USA007901). Additional information has been requested.
Age: 1.02
Sex: U
Vaccine: HEPA, HIBV, IPV, MMR, PNC13, VARCEL
Symptoms: Differential white blood cell count, Full blood count, Lymphadenopathy, Red blood cell sedimentation rate
Clinical narrative: Patient received immunization for well check visit on the 1st of July. Presented on 7/12 with bilateral inguinal node swelling turn to rubbery with no tenderness no fever.
Age: 4.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: Mom did not see it till now child c/o pain yesterday on left upper arm. No itching no fever. Using arm normally. 25 cm x 30 cm erythema and induration noted left lower upper arm.
Age: 5.0
Sex: F
Vaccine: MMRV
Symptoms: Pruritus, Rash papular, Scab, Skin discolouration
Clinical narrative: 5 pinpoint (approx. 2mm) areas of discoloration (red) and swelling (L) wrist area. 8 similar areas near (L) axilla - one of which is scabbed over. (L) knee with one approx. 3mm papule. Rashes noticed by sibling 7/9/13. (L) flank area itchy. No treatment.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Patient came to the pharmacy on 7-12-13. Her left arm was red. She pointed to the injection site and showed me a large red circle.
Age: 0.41
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Rash, Rash maculo-papular
Clinical narrative: Patient received vaccines on 7-10-13, per mother patient developed a rash on his face and chest 2-3 hrs after administration. Described as maculopapular. No treatment at this time.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Local reaction
Clinical narrative: Local reaction at injection site - whole area red and swollen where the zoster shot was given.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse (L.N.P.) refers to a patient of unknown age and gender. On 07-JUN-2013 the patient was vaccinated with a dose of GARDASIL (lot # H021608, exp. date 13-AUG-2013) (dose, route and site of administration not reported) which on an unknown date was exposed to minus 1C for 19 hours. No adverse effects reported. This was one of several reports received from the same source. This is one of 8 reports from the same source. Other linked reports are: MARRS # 1307USA006244, 1307USA006245, 1307USA006246, 1307USA006247, 1307USA006248, 1307USA006249, 1307USA006250. Additional information has been requested.
Age: 0.26
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PPV, RVX
Symptoms: Crying, Emotional distress, Flatulence, Pain
Clinical narrative: By this time, my child has usually moved her bowels at least once. At this time (11:54 PM), she has not. She woke up crying at approximately 10:00 PM after sleeping for nearly 5 hours and would not eat. She was also not easily consoled and has experienced worse gas than usual and seems to be painfully constipated.
Age: 1.0
Sex: M
Vaccine: HIBV, MMR, PNC13, VARCEL
Symptoms: Rash vesicular, Varicella post vaccine
Clinical narrative: Vesicular rash on arms and legs, suspect generalized varicella rash due to varicella vaccine administration.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Disturbance in attention, Eye swelling, Eyelid margin crusting, Fatigue, Headache
Clinical narrative: Fever 100.1, hard to concentrate, discomfort where injected, strong headache. Slept fitfully, fever broke 4am, returned 11am 100.0, with crusted eyes, bloodshot, rash all over, mild eye swelling, mild itch at injection site, legs rubbery, flu-like pains in body, arms very tired, feeling of exhaustion. Vaccine was 17 hours ago. Zostavax shingles vaccine.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Influenza like illness, Injection site discomfort, Injection site pruritus, Muscular weakness, Ocular hyperaemia
Clinical narrative: Fever 100.1, hard to concentrate, discomfort where injected, strong headache. Slept fitfully, fever broke 4am, returned 11am 100.0, with crusted eyes, bloodshot, rash all over, mild eye swelling, mild itch at injection site, legs rubbery, flu-like pains in body, arms very tired, feeling of exhaustion. Vaccine was 17 hours ago. Zostavax shingles vaccine.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Poor quality sleep, Pyrexia, Rash generalised
Clinical narrative: Fever 100.1, hard to concentrate, discomfort where injected, strong headache. Slept fitfully, fever broke 4am, returned 11am 100.0, with crusted eyes, bloodshot, rash all over, mild eye swelling, mild itch at injection site, legs rubbery, flu-like pains in body, arms very tired, feeling of exhaustion. Vaccine was 17 hours ago. Zostavax shingles vaccine.
Age: 34.0
Sex: F
Vaccine: HEPAB, PPV
Symptoms: Chills, Fatigue, Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: Swollen & red with deep muscle aches at injection site on right arm (where pneumonia vaccine was given.) Fatigue, chills, muscle aches over entire body. Slight fever.
Age: 34.0
Sex: F
Vaccine: HEPAB, PPV
Symptoms: Myalgia, Pyrexia
Clinical narrative: Swollen & red with deep muscle aches at injection site on right arm (where pneumonia vaccine was given.) Fatigue, chills, muscle aches over entire body. Slight fever.
Age: 65.0
Sex: M
Vaccine: HEPA, TDAP, TYP
Symptoms: Blood urine present
Clinical narrative: After taking the first of 4 typhoid capsules at bedtime, my first urine the next morning appeared to contain some small amount of blood.  Urine later in the day was clear.  This has occurred after taking each of the subsequent pills.  I have not seen a doctor to confirm the presents of blood.  I called the administrator of the vaccine to report the issue but was told they had never heard of such a side effect.
Age: 1.14
Sex: M
Vaccine: DTAP, HIBV, MMR, PNC13
Symptoms: Rash generalised
Clinical narrative: Started getting a rash in the evening after his shots, that started on his belly and now on July 13 2013 covers most of his body. It is a raised bumpy rash that we have not seen on him before his vaccinations.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Culture urine negative, Dysuria, Herpes simplex serology negative, Herpes zoster
Clinical narrative: Patient described injection with Zostavax as painful, although another patient was immunized five minutes earlier from same batch of vaccine and did not have a complaint. The patient that had pain developed a diffuse severe erythema and induration that extended from the injection site of right lateral upper extremity almost to the elbow with warmth and moderate tenderness to palpation the day after injection. Three weeks later, on 07/01 the patient experienced what was intially thought to be a UTI, with severe burning for two days but urinalysis was negative for UTI. Was placed on antibiotics and pyridium with no relief. Two days later a very painful skin eruption occurred with labial blisters appearing clinically like HSVII lesions. Pt was monogamous with a disabled spouse and no sexual encounters for a period of seven years prior and no history of std diagnosis or exposure. Subsequent HSVI and II serum testing resulted negative. Patient was empirically started on a regimen of Ciprofloxacin 500 mg BID X 7 days and Acyclovir 400 mg 5Xday. Blood collection was taken for additional testing for Herpes Zoster infection and was positive for active infection.  Blisters eventually resolved after a period of five days, but patient described pain on a scale of 5/10 to labia, lower buttock and hip for an additional 6 days before finally resolving. Interestingly enough, an additional person, male aged 65 who was a close contact with the patient developed a zoster like rash to his right maxillary area and extending to right eyelid and supraorbital region that subsequently also tested positive for Herpes Zoster. He was started on acyclovir in the same dosage and the rash resolved very quickly without further complication.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth, Pain
Clinical narrative: Patient described injection with Zostavax as painful, although another patient was immunized five minutes earlier from same batch of vaccine and did not have a complaint. The patient that had pain developed a diffuse severe erythema and induration that extended from the injection site of right lateral upper extremity almost to the elbow with warmth and moderate tenderness to palpation the day after injection. Three weeks later, on 07/01 the patient experienced what was intially thought to be a UTI, with severe burning for two days but urinalysis was negative for UTI. Was placed on antibiotics and pyridium with no relief. Two days later a very painful skin eruption occurred with labial blisters appearing clinically like HSVII lesions. Pt was monogamous with a disabled spouse and no sexual encounters for a period of seven years prior and no history of std diagnosis or exposure. Subsequent HSVI and II serum testing resulted negative. Patient was empirically started on a regimen of Ciprofloxacin 500 mg BID X 7 days and Acyclovir 400 mg 5Xday. Blood collection was taken for additional testing for Herpes Zoster infection and was positive for active infection.  Blisters eventually resolved after a period of five days, but patient described pain on a scale of 5/10 to labia, lower buttock and hip for an additional 6 days before finally resolving. Interestingly enough, an additional person, male aged 65 who was a close contact with the patient developed a zoster like rash to his right maxillary area and extending to right eyelid and supraorbital region that subsequently also tested positive for Herpes Zoster. He was started on acyclovir in the same dosage and the rash resolved very quickly without further complication.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain of skin, Rash, Urine analysis normal, Varicella virus test positive
Clinical narrative: Patient described injection with Zostavax as painful, although another patient was immunized five minutes earlier from same batch of vaccine and did not have a complaint. The patient that had pain developed a diffuse severe erythema and induration that extended from the injection site of right lateral upper extremity almost to the elbow with warmth and moderate tenderness to palpation the day after injection. Three weeks later, on 07/01 the patient experienced what was intially thought to be a UTI, with severe burning for two days but urinalysis was negative for UTI. Was placed on antibiotics and pyridium with no relief. Two days later a very painful skin eruption occurred with labial blisters appearing clinically like HSVII lesions. Pt was monogamous with a disabled spouse and no sexual encounters for a period of seven years prior and no history of std diagnosis or exposure. Subsequent HSVI and II serum testing resulted negative. Patient was empirically started on a regimen of Ciprofloxacin 500 mg BID X 7 days and Acyclovir 400 mg 5Xday. Blood collection was taken for additional testing for Herpes Zoster infection and was positive for active infection.  Blisters eventually resolved after a period of five days, but patient described pain on a scale of 5/10 to labia, lower buttock and hip for an additional 6 days before finally resolving. Interestingly enough, an additional person, male aged 65 who was a close contact with the patient developed a zoster like rash to his right maxillary area and extending to right eyelid and supraorbital region that subsequently also tested positive for Herpes Zoster. He was started on acyclovir in the same dosage and the rash resolved very quickly without further complication.
Age: 34.0
Sex: F
Vaccine: MMR
Symptoms: Dizziness, Feeling hot, Immediate post-injection reaction, Loss of consciousness, Pallor
Clinical narrative: Pt complaining immediately of feeling light-headed and feeling very hot. She said that she "blacked out" for a few seconds. Pt appeared very pale. Pt sat on chair for approximately 15 min. Said she felt better before leaving Rx.
Age: 13.0
Sex: F
Vaccine: HEPA
Symptoms: Dizziness, Dyspnoea, Heart rate increased, Pharyngeal oedema, Urticaria
Clinical narrative: Throat swelling, trouble breathing, hives, rapid heartbeat & dizziness. About 10 minutes after having received vaccination.
Age: 14.0
Sex: M
Vaccine: HPV4
Symptoms: Loss of consciousness, Malaise, Vomiting
Clinical narrative: Patient reported feeling sick and he passed out while walking to lobby to sit down.  Upon regaining consciousness, he vomited.  He then showed no further symptoms/side effects. Nurses checked his blood pressure; he was then cleared and released.
Age: 65.0
Sex: M
Vaccine: PPV
Symptoms: Abdominal pain upper, Decreased appetite, Fatigue, Injection site pain, Malaise
Clinical narrative: Pain at injection site. Difficulty moving arm X 24 hours; malaise; body ache; exhaustion; belly pain; nausea; anorexia all X 24-30 hours.
Age: 65.0
Sex: M
Vaccine: PPV
Symptoms: Mobility decreased, Nausea, Pain
Clinical narrative: Pain at injection site. Difficulty moving arm X 24 hours; malaise; body ache; exhaustion; belly pain; nausea; anorexia all X 24-30 hours.
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Fatigue, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Laboratory test
Clinical narrative: Numbness starting in feet and hands and then spread to arms, legs, neck and face.  Diagnosed with GBS.  IVG treatments.  Left foot and both hands continue to be severely numb.  At times, the numbness migrates to other parts of the body and fatigue is still present.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Swelling, redness, itching.  Advised home care ice and antihistamines.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Skin reaction
Clinical narrative: Localize reaction at injection site. Patient did not have SOB or other systemic symptoms. Localized reaction was redness and itching.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site vesicles
Clinical narrative: Small blister at site of IPV injection. Antibiotic ointment.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Culture negative, Injection site erythema, Injection site pustule, Scar
Clinical narrative: Red blister like pustules on arm that the injection was given in. Appeared from wrist to shoulder. Given clobetasol from MD and symptoms resolved some minor scarring remained.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a nurse via field representative refers to a female patient of unknown age. Patient received the ZOSTAVAX (strength, formulation, lot#, dose/frequency, route and duration were unspecified) 2-3 years ago(about in 2010 or 2011) and developed the Shingles 3-6 months ago(in 2013). Patient had sought medical attention via going back to HCP. The outcome of shingles was unknown. Additional information is not expected.
Age: 15.0
Sex: F
Vaccine: HPVX, TDAP
Symptoms: Death, Influenza, Multi-organ failure, Staphylococcal infection, Viral sepsis
Clinical narrative: This case was reported in a literature article and described the occurrence of multiorgan failure in a 15-year-old female subject who was vaccinated with Tdap (manufacturer unspecified) and HPV vaccine (manufacturer unspecified). On an unspecified date, the subject received an unspecified dose of Tdap (administration site and route unknown, batch number not provided) and an unspecified dose of HPV vaccine (administration site and route unknown, batch number not provided). 58 days after vaccination with Tdap and HPV vaccine, the subject experienced multiorgan failure, influenza B viral sepsis and staphylococcal secondary infection and died. It was unknown whether an autopsy was performed. This is one of the 11 cases from the same literature article. Summary of the literature article: Pre-licensure clinical trials for two licensed Tdap vaccines did not reveal any major safety concerns. However, routine use in large adolescent and adult populations could reveal rare and potentially serious adverse events (AEs). To characterize reported AEs following Tdap vaccination and identify potential safety concerns warranting further evaluation, we analyzed data from the Vaccine Adverse Event Reporting System (VAERS) and assessed the frequency and proportions of AEs and reporting rates (reports per 100,000 vaccine doses distributed). A total of 2090 reports (7% were serious; 55% listed Tdap alone) involving Tdap vaccines were submitted to VAERS May 2005 - June 2007. The crude reporting rate was 10.2 per 100,000 vaccine doses distributed. The median age of vaccinees was 22 years, and the female to male ratio was about 2 to 1. The majority of reports described common local and systemic signs and symptoms, such as injection site reactions, fever, and headache. Rarely reported AEs included myopericarditis, demyelinating disease of the central nervous system, Guillain-Barre syndrome, syncope, encephalopathy/encephalitis, seizure, Bell's palsy, anaphylaxis, and thrombocytopenia. The author's conclusion stated that because adolescents and adults were not routinely vaccinated against pertussis in the past, this surveillance summary provides important - and reassuring - information about the use of Tdap in these age groups. Although subject to the limitations of passive surveillance, the findings of this VAERS review support the pre-licensure clinical trial data with regard to the safety of the licensed Tdap vaccines. Continued monitoring of clinically significant AEs that are temporally associated with Tdap vaccination and further assessment of such events using controlled observational studies may provide additional information about the safety of these vaccines.
Age: 16.0
Sex: F
Vaccine: HPVX, TDAP
Symptoms: Nuclear magnetic resonance imaging brain abnormal, Optic neuritis
Clinical narrative: This case was reported in a literature article and described the occurrence of optic neuritis in a 16-year-old female subject who was vaccinated with DTPa (with small D + P) (manufacturer unspecified), HPV (manufacturer unspecified). On an unspecified date, the subject received an unspecified dose of DTPa (with small D + P) (administration site and route unknown, batch number not provided) and an unspecified dose of HPV (administration site and route unknown, batch number not provided). 59 days after vaccination with DTPa (with small D + P) and HPV, the subject experienced left optic neuritis. This case was assessed as medically serious by GSK. Magnetic resonance imaging of the brain showed some slight enlargement of the left optic nerve. At the time of reporting, the outcome of the event was unspecified. This is one of the 11 cases created from the same literature article. Summary of the literature article: Pre-licensure clinical trials for two licensed tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines did not reveal any major safety concerns. However, routine use in large adolescent and adult populations could reveal rare and potentially serious adverse events (AEs). To characterize reported AEs following Tdap vaccination and identify potential safety concerns warranting further evaluation, we analyzed data from the Vaccine Adverse Event Reporting System (VAERS) and assessed the frequency and proportions of AEs and reporting rates (reports per 100,000 vaccine doses distributed). A total of 2090 reports (7% were serious; 55% listed Tdap alone) involving Tdap vaccines were submitted to VAERS May 2005 - June 2007. The crude reporting rate was 10.2 per 100,000 vaccine doses distributed. The median age of vaccinees was 22 years, and the female to male ratio was about 2 to 1. The majority of reports described common local and systemic signs and symptoms, such as injection site reactions, fever, and headache. Rarely reported AEs included myopericarditis, demyelinating diseases of the central nervous system, Guillain-Barre Syndrome, syncope, encephalopathy/encephalitis, seizure, Bell's palsy, anaphylaxis, and thrombocytopenia. The author's conclusion stated that because adolescents and adults were not routinely vaccinated against pertussis in the past, this surveillance summary provides important - and reassuring - information about the use of Tdap in these age groups. Although subject to the limitations of passive surveillance, the findings of this VAERS review support the pre-licensure clinical trial data with regard to the safety of the licensed Tdap vaccines. Continued monitoring of clinically significant AEs that are temporally associated with Tdap vaccination and further assessment of such events using controlled observational studies may provide additional information about the safety of these vaccines.
Age: 46.0
Sex: M
Vaccine: ANTH, FLUN3, HEPAB, SMALL, TYP
Symptoms: Cardiomyopathy, Echocardiogram abnormal, Electrocardiogram abnormal, Troponin I
Clinical narrative: This study case was received from the investigator in the trial on 03 July 2013. A 46 year-old male subject whose past medical history included high blood pressure, elevated cholesterol, palpitations/pounding heart without exercise and cardiomyopathy was found to have other primary cardiomyopathies 2 days after the subject had received the following vaccines on 25 August 2009: an injection of ACAM2000 (lot number, route and site of administration not reported), TYPHIM VI vaccine (lot number, route and site of administration not reported), Anthrax 1 (manufacturer, lot number, route and site of administration not reported), Hep A - Hep B (manufacturer, lot number, route and site of administration not reported) and Influenza live intranasal (manufacturer and lot not reported). On 09 September 2009, the subject's ECG and echocardiogram were abnormal. Results of Troponin 1 were not available. Lumbar puncture (spinal tap) and MRI of the brain, spinal cord and heart were not performed. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non interventional) study. Documents held by sender: none.
Age: 66.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Erythema, Injection site pruritus, Myalgia, Pruritus
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 66 year old male patient with abnormal "blood pressure" and diabetes. No history of drug reactions/allergies. On 14-JUN-2013 the patient was vaccinated with ZOSTAVAX (subcutaneous; lot# J000432; exp date: 10-APR-2014). Concomitant medications included unspecified medications for "blood pressure and diabetes". On 14-JUN-2013, 3 hrs after vaccination, the patient developed a red rash at the injection site and itching at injection site. The following day (15-JUN-2013) the rash spread and the itching continued. On 16-JUN-2013 the rash spread even further and the patient noted muscle soreness. The events were treated with ice and topical hydrocortisone (manufacturer unknown). The outcome was reported as not recovered. No lab diagnostics were performed. The patient sought medical attention by calling the pharmacy. Additional information has been requested.
Age: 66.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Myalgia
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 66 year old male patient with abnormal "blood pressure" and diabetes. No history of drug reactions/allergies. On 14-JUN-2013 the patient was vaccinated with ZOSTAVAX (subcutaneous; lot# J000432; exp date: 10-APR-2014). Concomitant medications included unspecified medications for "blood pressure and diabetes". On 14-JUN-2013, 3 hrs after vaccination, the patient developed a red rash at the injection site and itching at injection site. The following day (15-JUN-2013) the rash spread and the itching continued. On 16-JUN-2013 the rash spread even further and the patient noted muscle soreness. The events were treated with ice and topical hydrocortisone (manufacturer unknown). The outcome was reported as not recovered. No lab diagnostics were performed. The patient sought medical attention by calling the pharmacy. Additional information has been requested.
Age: 63.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Erythema, Injection site pruritus, Injection site rash, Injection site urticaria, Urticaria
Clinical narrative: ZOSTAVAX admin. 6/7/13 (L) tricep SQ; Pt. presented to pharmacy with red raised rash at site of injection. Highly pruritic. Recommended BENADRYL. Pt. also visited clinic - prescribed KEFLEX for skin infection from scratching.
Age: 63.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling, Skin infection
Clinical narrative: ZOSTAVAX admin. 6/7/13 (L) tricep SQ; Pt. presented to pharmacy with red raised rash at site of injection. Highly pruritic. Recommended BENADRYL. Pt. also visited clinic - prescribed KEFLEX for skin infection from scratching.
Age: 76.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema
Clinical narrative: Injection site reaction - redness, swelling, itching, size increased over time to now 3 inch diameter at 10 days post injection date.
Age: 76.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Injection site reaction - redness, swelling, itching, size increased over time to now 3 inch diameter at 10 days post injection date.
Age: 55.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Right arm sore, swelling; Large Red swollen spot at site. Then even larger (4") pink circle encompassing the Red circle. Hot, itchy and thick swelling. Dr. prescribed KEFLEX antibiotic. Diagnosed as Cellulitis and infected.
Age: 55.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Cellulitis, Infection, Injection site erythema, Injection site swelling, Local swelling
Clinical narrative: Right arm sore, swelling; Large Red swollen spot at site. Then even larger (4") pink circle encompassing the Red circle. Hot, itchy and thick swelling. Dr. prescribed KEFLEX antibiotic. Diagnosed as Cellulitis and infected.
Age: 55.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain in extremity, Pruritus, Skin warm, Swelling
Clinical narrative: Right arm sore, swelling; Large Red swollen spot at site. Then even larger (4") pink circle encompassing the Red circle. Hot, itchy and thick swelling. Dr. prescribed KEFLEX antibiotic. Diagnosed as Cellulitis and infected.
Age: 51.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Left arm sore, swelling, redness. The redness spread out to a large 5" area and got thick and hot. Doctor prescribed KEFLEX antibiotic. Diagnosed as cellulitis/infection.
Age: 51.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Cellulitis, Erythema, Infection, Local swelling, Pain in extremity
Clinical narrative: Left arm sore, swelling, redness. The redness spread out to a large 5" area and got thick and hot. Doctor prescribed KEFLEX antibiotic. Diagnosed as cellulitis/infection.
Age: 51.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Skin warm
Clinical narrative: Left arm sore, swelling, redness. The redness spread out to a large 5" area and got thick and hot. Doctor prescribed KEFLEX antibiotic. Diagnosed as cellulitis/infection.
Age: 31.0
Sex: M
Vaccine: TDAP
Symptoms: Erythema, Rash
Clinical narrative: Rash / redness on upper body.
Age: 6.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site rash
Clinical narrative: 7/9/13 Pt's father sent in a question on pt's my chart attaching a photo of patient's arm. Patient's Dad states that the reaction, which is rash, started on the day the vaccine was given. Spoke with patient's Dad 7/12/13, as per Dad, it got better and was completely gone.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Rash
Clinical narrative: ZOSTAVAX admin (L) tricep SQ 6/27/13; on 6/29/13 pt reported to pharmacy with 3-4 inch red raised rash at site of injection and multiple spots on chest, back and legs. BENADRYL recommended.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMRV
Symptoms: Injection site erythema, Injection site induration, Injection site infection, Injection site pruritus, Injection site swelling
Clinical narrative: Father stated child that on July 10th the child had a red area on the left leg that he thought was a bug bite. On July 11th the area was red, swollen, hard, itchy, warm to touch and the size of a baseball. Advised to seek medical care. Parent took child to Urgent Care and was told child had an "infection in the muscle." Child received a prescription for Bactrim. On the 12th parent reported the area was no bigger.  On the 15th parents states child has fully recovered.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMRV
Symptoms: Injection site warmth
Clinical narrative: Father stated child that on July 10th the child had a red area on the left leg that he thought was a bug bite. On July 11th the area was red, swollen, hard, itchy, warm to touch and the size of a baseball. Advised to seek medical care. Parent took child to Urgent Care and was told child had an "infection in the muscle." Child received a prescription for Bactrim. On the 12th parent reported the area was no bigger.  On the 15th parents states child has fully recovered.
Age: 1.02
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Blood culture negative, Condition aggravated, Culture urine negative, Febrile convulsion, Full blood count normal
Clinical narrative: Acute fever (101.8-102 degrees F), febrile seizure (patient with hx of febrile seizures in the past), then rash developed on trunk, spread to generalized papular presentation. Presumed varicella-like rash. Mild pruritus.
Age: 1.02
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Mononucleosis heterophile test negative, Pruritus, Pyrexia, Rash, Rash generalised
Clinical narrative: Acute fever (101.8-102 degrees F), febrile seizure (patient with hx of febrile seizures in the past), then rash developed on trunk, spread to generalized papular presentation. Presumed varicella-like rash. Mild pruritus.
Age: 1.02
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Rash papular, Viral pharyngitis
Clinical narrative: Acute fever (101.8-102 degrees F), febrile seizure (patient with hx of febrile seizures in the past), then rash developed on trunk, spread to generalized papular presentation. Presumed varicella-like rash. Mild pruritus.
Age: 9.0
Sex: F
Vaccine: HEPA, TD
Symptoms: Eye swelling, Facial paresis, Lacrimation increased
Clinical narrative: MOTHER REPORTS MILD WEAKNESS TO LOWER HALF OF LEFT SIDE OF FACE FROM MOUTH TO JAW. ALSO REPORTS INCREASED TEARING OF LT EYE WITH MILD SWELLING. MOTHER STATES PLACED "REFRESH" DROPS ONTO LT EYE. MOTHER REPORTED TO CLINIC HDC WITH COMPLAINTS ON 7/15/2013 AT 10:00 AM. SENT TO CLINIC TO EVAL.
Age: 73.0
Sex: F
Vaccine: PPV
Symptoms: Injection site inflammation, Injection site pain
Clinical narrative: Inflammation and very painful at the injection site.  Told to take Benadryl by physician on 7/14.  On 7/15 patient reports still there but feeling better around injection area.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Burning sensation, Headache, Influenza like illness, Swelling face
Clinical narrative: Facial swelling, arm burning, stomach upset, headache on 7/10/13. On 7/11 facial swelling subsided, arm burning worsened, felt flu-like symptoms, called the pharmacy late evening where administered for consultation was told oral Benadryl and call MD in AM to report to them. On 7/12 no change in symptoms, consulted with MD, was told Benadryl cream and cold compresses.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Musculoskeletal pain, Neck pain, X-ray
Clinical narrative: Severe shoulder and neck deep pain. 05/28/2013 pain meds prescribed. 06/03  x-rays gabapentine prescribed.
Age: 9.0
Sex: F
Vaccine: HEPA
Symptoms: Nausea, Pyrexia, Somnolence, Vomiting
Clinical narrative: Patients mother reported severe vomiting, nausea, fever and extended sleep.
Age: 8.0
Sex: M
Vaccine: FLU3, HEPA
Symptoms: Blood catecholamines, Blood catecholamines normal, CSF glucose increased, Catecholamines urine normal, Computerised tomogram head normal
Clinical narrative: Woke up with very bad headache and was screaming and crying for 5 min, mom gave him Tylenol and his headache started improving and he was back to normal in about an hour. He continued to do fine until later that evening when at 6:30 pm while getting out of the shower he started having severe headache again suddenly and started screaming again, mom tried giving him Tylenol which helped a little but he continued to have the headache and vomited 6 times so he was brought to the ER where BP was 146/82 on arrival and went up to 196/124. CT scan head was negative and lumbar puncture showed normal CSF except for elevated glucose. Diagnosed with hypertensive urgency, work-up was suggestive of catecholamine mediated hypertension. Imaging studies, that included MRI of abdomen/pelvis and head as wall as an MIBG scan were negative. Repeat urine and plasma studies for catecholamines and metanephrines were negative. Needed 2 anti-hypertensive medications with good effect and discharged home after 20 days in the hospital. Guanfacine, started 1 month prior to this episode was continued. Over the next 2 months, we were able to stop his antihypertensive medications. In the past 4 months, without anti-hypertensive medications, he has not had recurrence of headaches or hypertension.
Age: 8.0
Sex: M
Vaccine: FLU3, HEPA
Symptoms: Crying, Headache, Hypertensive crisis, Lumbar puncture normal, Metanephrine urine normal
Clinical narrative: Woke up with very bad headache and was screaming and crying for 5 min, mom gave him Tylenol and his headache started improving and he was back to normal in about an hour. He continued to do fine until later that evening when at 6:30 pm while getting out of the shower he started having severe headache again suddenly and started screaming again, mom tried giving him Tylenol which helped a little but he continued to have the headache and vomited 6 times so he was brought to the ER where BP was 146/82 on arrival and went up to 196/124. CT scan head was negative and lumbar puncture showed normal CSF except for elevated glucose. Diagnosed with hypertensive urgency, work-up was suggestive of catecholamine mediated hypertension. Imaging studies, that included MRI of abdomen/pelvis and head as wall as an MIBG scan were negative. Repeat urine and plasma studies for catecholamines and metanephrines were negative. Needed 2 anti-hypertensive medications with good effect and discharged home after 20 days in the hospital. Guanfacine, started 1 month prior to this episode was continued. Over the next 2 months, we were able to stop his antihypertensive medications. In the past 4 months, without anti-hypertensive medications, he has not had recurrence of headaches or hypertension.
Age: 8.0
Sex: M
Vaccine: FLU3, HEPA
Symptoms: Nuclear magnetic resonance imaging abdominal normal, Nuclear magnetic resonance imaging brain normal, Scan adrenal gland, Screaming, Vomiting
Clinical narrative: Woke up with very bad headache and was screaming and crying for 5 min, mom gave him Tylenol and his headache started improving and he was back to normal in about an hour. He continued to do fine until later that evening when at 6:30 pm while getting out of the shower he started having severe headache again suddenly and started screaming again, mom tried giving him Tylenol which helped a little but he continued to have the headache and vomited 6 times so he was brought to the ER where BP was 146/82 on arrival and went up to 196/124. CT scan head was negative and lumbar puncture showed normal CSF except for elevated glucose. Diagnosed with hypertensive urgency, work-up was suggestive of catecholamine mediated hypertension. Imaging studies, that included MRI of abdomen/pelvis and head as wall as an MIBG scan were negative. Repeat urine and plasma studies for catecholamines and metanephrines were negative. Needed 2 anti-hypertensive medications with good effect and discharged home after 20 days in the hospital. Guanfacine, started 1 month prior to this episode was continued. Over the next 2 months, we were able to stop his antihypertensive medications. In the past 4 months, without anti-hypertensive medications, he has not had recurrence of headaches or hypertension.
Age: 20.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Induration, Skin warm, Swelling
Clinical narrative: 20 yr. old, female, received varicella vaccine in (L) subq. developed 4 1/2 x 3 1/2" area of redness and swelling. 2" dark red, hard warm to touch.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Injection site erythema, Injection site urticaria, Urticaria
Clinical narrative: 20 minutes after injection of vaccines, patient was noted to have first some redness around the site of PENTACEL injection and then urticarial like reaction around the sites of both sets of injections and on his abdomen. Positive dermatographia with these noted. He was given 3mL BENADRYL in office. Lips and tongue normal. Breathing normal. Normal pulses. Repeat BENADRYL 3mL every 6 hours as needed.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: Site on (R) arm swollen and red. When to MD 1/9/13 - Dx with cellulitis on antibiotic.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Aphagia, Asthenia, Dry mouth, Nausea, Weight decreased
Clinical narrative: Received shot 6-26-13 - 1:30 PM. Symptoms started 6 PM- on 6-26-13. Weakness and very nauseated. On 6-27-13 woke up still nauseas and weak. Could not eat, dry mouth. Forced piece of toast with swallows of water. This continued all day until 6 PM of 6-27-2013. Weight loss 3 pounds.
Age: 1.21
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Poor quality sleep, Pyrexia
Clinical narrative: Became febrile Fri, 6-28, after receiving Dtap, not sleeping well, underneath eyes red, then cont'd temp thru Mon AM temp 102 degrees to 105. TYLENOL PRN. Office visit 7-1-13; possible roseola.
Age: 1.69
Sex: M
Vaccine: HIBV, VARCEL
Symptoms: Convulsion, Electroencephalogram, Musculoskeletal stiffness, Nuclear magnetic resonance imaging brain, Respiratory arrest
Clinical narrative: My son had a seizure which lasted around 10 minutes. He was stiff, non responsive, stopped breathing. Had no fever at the time of seizure.
Age: 1.69
Sex: M
Vaccine: HIBV, VARCEL
Symptoms: Unresponsive to stimuli
Clinical narrative: My son had a seizure which lasted around 10 minutes. He was stiff, non responsive, stopped breathing. Had no fever at the time of seizure.
Age: 6.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Abdominal pain upper, Headache, Injection site rash, Lethargy, Pyrexia
Clinical narrative: D1 fever 103, headache, stomach ache, lethargy, rash started on back - multiple red papules D2 rash spread to proximal upper arms, back of neck, seen on ofc and dx possible varicella vs insect bite. D3 phone to mom - lesions on back crusty, oozing clear liq looked like tear drops before breaking, vomiting.
Age: 6.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash, Rash papular, Scab, Secretion discharge, Skin lesion
Clinical narrative: D1 fever 103, headache, stomach ache, lethargy, rash started on back - multiple red papules D2 rash spread to proximal upper arms, back of neck, seen on ofc and dx possible varicella vs insect bite. D3 phone to mom - lesions on back crusty, oozing clear liq looked like tear drops before breaking, vomiting.
Age: 6.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Vomiting
Clinical narrative: D1 fever 103, headache, stomach ache, lethargy, rash started on back - multiple red papules D2 rash spread to proximal upper arms, back of neck, seen on ofc and dx possible varicella vs insect bite. D3 phone to mom - lesions on back crusty, oozing clear liq looked like tear drops before breaking, vomiting.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site rash
Clinical narrative: 7 cm x 6 cm circular rash with 1 cm round center on left thigh.
Age: 23.0
Sex: U
Vaccine: TDAP
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node under left arm pit.
Age: 44.0
Sex: F
Vaccine: HEPA, TYP, YF
Symptoms: Pruritus, Rash erythematous, Rash generalised
Clinical narrative: Red raised 2mm bumps appeared on (B) lower legs, forearms 9 days post vaccines. Day 10 the bumps appeared on chest, abdomen, thighs, feet, hands. Small amount on lower legs and forearms, moderate-severe on thighs. Very itchy. Applied rubbing alcohol to rash several times a rash. Resolved within 7-8 days. No other symptoms with rash.
Age: 1.28
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Immunisation reaction, Rash generalised
Clinical narrative: Rash began 7/4/13 on stomach, back, legs, neck and head. Patient came "into the office 7/5/13. Dx Post immunization reaction - stop the Hep A series.
Age: 54.0
Sex: F
Vaccine: ANTH
Symptoms: Asthenia, Headache, Hypoaesthesia, Influenza, Pain
Clinical narrative: High fever, aches, pains - started 16 Jun. Severe HA 18 Jun. Loss of feeling (R) arm and weakness - started 22 Jun and has continued again flu symptoms 1-2 Jul.
Age: 54.0
Sex: F
Vaccine: ANTH
Symptoms: Pyrexia
Clinical narrative: High fever, aches, pains - started 16 Jun. Severe HA 18 Jun. Loss of feeling (R) arm and weakness - started 22 Jun and has continued again flu symptoms 1-2 Jul.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HEP, PNC13
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 2 Hep B shots at the same time.
Age: 26.0
Sex: F
Vaccine: MMR
Symptoms: Pruritus, Rash, Sensation of heaviness
Clinical narrative: Head itching - 2 hours after received MMR and PPD. Before 12 PM TST site (forearm) itching. Later afternoon new itching and localized skin rash. Denied trouble breathing but feeling of heaviness at times. Seen in E.R. Medication given - Epinephrine, Solumedrol, Pepcid, ZOFRAN and BENADRYL. Treated in E.R. by P.A.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Local reaction
Clinical narrative: Large local reaction (erythema, swelling, tenderness) on injection site with blotchy skin all around deltoid muscle.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Rash macular
Clinical narrative: Large local reaction (erythema, swelling, tenderness) on injection site with blotchy skin all around deltoid muscle.
Age: 1.26
Sex: M
Vaccine: MMR
Symptoms: Blood culture negative, Culture urine negative, Lumbar puncture normal, Pyrexia
Clinical narrative: Pt had febrile 12 days after MMR.
Age: 4.0
Sex: M
Vaccine: PNC13
Symptoms: Rash
Clinical narrative: Presented rash in the area of the chest and back.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Patient hospitalized for high fever.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Pruritus, Tenderness
Clinical narrative: Pt. developed redness at site of injection and itching. 2 days later developed 3 dime size spots in line on upper arm of injection. Tender and itchy.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Abscess limb, Cellulitis, Erythema
Clinical narrative: Erythremia / Cellulitis Abscess arm - Upper Rt.
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: Delirium, Pyrexia, Vomiting
Clinical narrative: 10-12 hour of fever, emesis, delirious per Mom after BOOSTRIX.
Age: 1.01
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: (L) thigh swollen and red. No pain swelling decreasing ~ cool compresses as needed.
Age: 63.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Sore arm below site very mild red area < 1" round at inj. site. No drainage no lumps at inj. site. Muscle soft supple no lumps. Counseled pt on site s/s infection; use heat or ice for comfort and Ibuprofen.
Age: 11.0
Sex: M
Vaccine: TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Mother noticed redness, swelling at injection site. Some pain to touch. 2 days later, site was warm to touch and area had widened. On 3rd day was brought to office and seen by Nurse Practitioner for the pain, redness, swelling, low grade fever. Given KEFLEX 500mg TID x 10 day.
Age: 6.0
Sex: F
Vaccine: DTAP
Symptoms: Erythema, Injection site erythema, Injection site warmth
Clinical narrative: About 24 hrs after vaccine, site (Lt thigh) noted to be red and warm. Brought to office 7/12/13 - area around vaccine site red - 5 cm x 6 cm. Additional 3x4 cm area of redness noted Lt. lower abd - treated with antibiotics.
Age: 54.0
Sex: F
Vaccine: TDAP
Symptoms: Arthralgia, Asthenia, Headache, Injection site erythema, Injection site pruritus
Clinical narrative: Day 1 Headache, nausea TYLENOL. Day 2 Upper arm swollen, red, fever 102 TYLENOL. Day 3 All joints painful, generalized weakness, fever, HA, nausea TYLENOL. Day 4 Left arn itching ice pack. Day 5 Swelling decreased.
Age: 54.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site swelling, Nausea, Pyrexia
Clinical narrative: Day 1 Headache, nausea TYLENOL. Day 2 Upper arm swollen, red, fever 102 TYLENOL. Day 3 All joints painful, generalized weakness, fever, HA, nausea TYLENOL. Day 4 Left arn itching ice pack. Day 5 Swelling decreased.
Age: 42.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pain, Pyrexia
Clinical narrative: Fever, Rt. shoulder pain.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Discomfort, Injection site swelling, Oedema peripheral
Clinical narrative: MENACTRA vaccine administered 7/12/13. That evening swelling started to impact site left deltoid and swollen area under left arm in arm pit. Came back to health department 7/15/13. Swelling noted to injection site and left armpit. Patient reports swelling has gone down, no treatment seeked - and take ibuprofen for discomfort over weekend.
Age: 39.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Back pain, Body temperature increased, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Left deltoid swelling, redness, warmth and pain. Temp last evening (Sun) 7-14 of 100 orally. Lower back achiness as well as systemic myalgia, afebrile today Monday 7-15-13 given script for KEFLEX 500 mg  TID for 7 days (daily if needed) oral temp spikes again.
Age: 39.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Injection site warmth, Myalgia
Clinical narrative: Left deltoid swelling, redness, warmth and pain. Temp last evening (Sun) 7-14 of 100 orally. Lower back achiness as well as systemic myalgia, afebrile today Monday 7-15-13 given script for KEFLEX 500 mg  TID for 7 days (daily if needed) oral temp spikes again.
Age: 39.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Back pain, Pyrexia, Swelling
Clinical narrative: Left deltoid swelling, redness, warmth and pain. Temp last evening (Sun) 7-14 of 100 orally. Lower back achiness as well as systemic myalgia, afebrile today Monday 7-15-13 given script for KEFLEX 500 mg  TID for 7 days (daily if needed) oral temp spikes again.